Cyclerion Therapeutics, Inc. Profile Avatar - Palmy Investing

Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant…

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CYCN's Analysis
CIK: 1755237 CUSIP: 23255M105 ISIN: US23255M2044 LEI: - UEI: -
Secondary Listings
CYCN has no secondary listings inside our databases.